Seqel Appoints Mark Fletcher as Chief Science Officer at Douglas Pharmaceuticals Ltd

01 Mar Seqel Appoints Mark Fletcher as Chief Science Officer at Douglas Pharmaceuticals Ltd

Douglas Pharmaceuticals, New Zealand’s largest pharmaceutical development and manufacturing company in Oceania, appoints Mark Fletcher as Chief Science Officer. Mark has migrated from the United States, previously being employed as VP Technical Operations & Regulatory Affairs for PBM Pharmaceuticals. He has a global pedigree background in pharmaceutical development, having proven himself in pharmaceutical formulations and operations.

<< Go Back